Skip Ribbon Commands
Skip to main content
Menu

Grants FY20-21

NMRC

  • “The role of Caveolin-1 in Ocular Neurovascular Coupling”.
    Dr Rachel Chong; S$20,000.00

  • “Evaluation of Safety and Efficacy of Subconjunctival Injection of Liposomal Tacrolimus for Allergic Conjunctivitis”.
    Prof Jodhbir Mehta; S$208,333.33

  • “Wireless Miniaturised GonioPEN for Irido-corneal Imaging”.
    Assoc Prof Shamira Perera; S$208,333.33

  • “Digital Technology Solutions to Improve the Vision-specific Quality of Life and Social Engagement in the Visual Impaired Older Population- A Pilot Study”
    Dr Anna Tan; S$498,000.00

  • “Optimising Surgical Management and Patient-related Outcomes of Epiretinal Membrane: Predictive Analytics and Randomised Trial”
    Dr Cheung Ning; S$674,938.50

  • “Using Novel Imaging Biomarkers to Predict Vascular Endothelial Growth Factor Inhibitor Retreatment Load for Neovascular Age Related Macular Degeneration”
    Dr Kelvin Teo; S$375,000.00

  • “Singapore Angle Closure Glaucoma Program: From Genetics to Precision Medicine and Therapy”
    Prof Aung Tin; S$4,160,478.00

  • “Development of a SPARC Silencing Delivery System: A Targeted Approach for Treating Fibrosis Following Glaucoma Filtration Surgery”
    Prof Tina Wong; S$238,095.00

  • “DR COVID – A Multi-lingual Artificial Intelligence Virtual System with Audio-visual Technology for COVID-19”
    Dr Daniel Ting; S$982,000.00

  • “Precision Medicine using Single Cell Genomics, Transcriptomics, Proteomics and Lipidomics in Fluid Biopsies to Diagnose and Manage Primary Vitreoretinal Lymphoma”
    Dr Anita Chan; S$1,405,637.51

  • “Digital Technology Solutions to Improve the Vision-specific Quality of Life”
    Dr Anna Tan; S$57,995.00

  • “A Biomechanical Sensing Model of Scleral Remodeling in High Myopia”
    Dr Donny Hoang; S$1,407,429.65

  • “The Role of Caveolin-1 in Inner Retina Neurovascular Coupling in Experimental Glaucoma”
    Dr Rachel Chong; S$199,999.00


A*Star/ Duke-NUS/ MOH/ Others

  • “Transforming Vision Evaluation and Dilation in the Care of Ophthalmic Patients”.
    Dr Gavin Tan; S$49,999.20

  • “Translating MSC Exosomes into Pharmaceuticals”
    Prof Jodhbir Mehta and Dr Ong Hon Shing; S$1,032,585.00

  • “Digital Technology Solutions to Improve the Vision-specific Quality of Life and Social Engagement in the Visual Impaired Older Population - A Pilot Study”
    Dr Anna Tan; S$28,012.00

  • “Retinal Analytics via Machine Learning Aiding Physics”
    Prof Aung Tin; S$1,200,000.00

  • “Future Health Technologies (“FTH”) Module 1 “Fractures and Falls” - Early Detection of Health Risks and Prevention”
    Prof Ecosse Lamoureux; S$1,136,676.00

  • “Digital Technology in Ophthalmology”
    Prof Wong Tien Yin; S$150,000.00


SingHealth

  • “From Machine to Machine - Developing a Deep Learning Algorithm for Quantification of Ocular Traits based on Retinal Photographs”.
    Dr Tyler Rim Hyungtaek; S$100,000.00

  • “COVID-19 Pandemic: Triaging of ‘Only Urgent Eye Referrals’ from Polyclinics (TOP) using Retinal Photograph-based Deep Learning”.
    Dr Tham Yih Chung; S$28,500.00

  • “Choroidal All-trans Retinoic Acid Involvement in the Local Control of Eye Growth in Myopia Development”.
    Dr Jiang Liqin; S$49,500.00

  • “The Role of the Aging Visual Function System on Functional Health in Elderly Singaporeans”.
    Dr Preeti Gupta; S$149,889.00

  • “Task Shifting Intravitreal Injection from Ophthalmologists to Nurses: A Prospective Randomized Non-inferiority Trial”.
    Assoc Prof Ian Yeo; S$65,000.00


Commercial

  • “An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost Sustained Release (SR) in Patients with Open Angle Glaucoma (OAG) or Ocular Hypertension (OHT)”
    Assoc Prof Shamira Perera; S$46,995.33

  • “Safety and Efficacy of the Laser Scleral Microporation Procedure to Restore Effective Range of Focus in Macaque Non-human Primates”
    Dr Liu Yu Chi; S$155,134.06

  • “A Phase III, Multicenter, Randomized, Double-masked, Active Comparator-controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients with Macular Edema Secondary to Branch Retinal Vein Occlusion (BALATON)”
    Dr Anna Tan; S$36,239.13

  • “Evaluating a Soft Contact Lens for Myopia Control”
    Assoc Prof Audrey Chia; S$595,794.01

  • “Convenient and Standardized Forced Visual Acuity Testing in Dry Eye Patients”
    Prof Louis Tong; S$9,757.50

  • “A Phase III, Multicenter, Randomized, Double-masked, Active Comparator-controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients with Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion (COMINO)”
    Dr Anna Tan; S$36,239.13

  • “The Evaluation of Nano-neural Growth Factor on Corneal Nerve Regeneration – In Vivo Study of NGF Release Profiles (Phase 2)”
    Dr Liu Yu Chi; S$243,870.33

  • “Endotoxin-induced Uveitis Model (EIU) as the Animal Model to Test Efficacy of IC-265”
    Dr Amutha Barathi; S$65,265.72

  • “Randomized, Double-masked, Active-controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients with Neovascular Age-related Macular Degeneration (PULSAR)”
    Prof Gemmy Cheung; S$150,931.05

  • “POC of Reopia Optics Lenses on Chick Model”
    Dr Amutha Barathi; S$10,037.46